US2007231259A1PendingUtilityA1

Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production

Assignee: BASF AGPriority: Jun 25, 1999Filed: Aug 15, 2006Published: Oct 4, 2007
Est. expiryJun 25, 2019(expired)· nominal 20-yr term from priority
C12P 13/227C12N 9/18C12P 13/24C12P 7/18C12P 13/04C12N 9/00C12Y 301/01031C07K 2319/00C12P 7/6409C12P 13/06C12N 9/90C12P 13/12C12P 13/225C12P 7/6463C12P 13/10C12P 19/00C12P 13/20C12P 19/34C12P 13/222C12P 7/40C07K 14/34C12P 13/14C12P 13/08
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Isolated nucleic acid molecules, designated SMP nucleic acid molecules, which encode novel SMP proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SMP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated SMP proteins, mutated SMP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of SMP genes in this organism.

Claims

exact text as granted — not AI-modified
1 . An isolated nucleic acid molecule selected from the group consisting of 
 a) an isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:85, 87 or 89, or a complement thereof;    b) an isolated nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:86, 88 or 90, or a complement thereof;    c) an isolated nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence of SEQ ID NO: 86, 88 or 90, or a complement thereof;    d) an isolated nucleic acid molecule comprising a nucleotide sequence which is at least 50% identical to the entire nucleotide sequence of SEQ ID NO:85, 87 or 89, or a complement thereof; and    e) an isolated nucleic acid molecule comprising a fragment of at least 15 contiguous nucleotides of the nucleotide sequence of SEQ ID NO:85, 87 or 89, or a complement thereof.    
     
     
         2 . The isolated nucleic acid molecule of  claim 1 , wherein said nucleic acid molecule encodes a protein involved in the production of a fine chemical.  
     
     
         3 . An isolated nucleic acid molecule comprising the nucleic acid molecule of  claim 1  and a nucleotide sequence encoding a heterologous polypeptide.  
     
     
         4 . A vector comprising the nucleic acid molecule of  claim 1 .  
     
     
         5 . The vector of  claim 4 , which is an expression vector.  
     
     
         6 . A host cell transfected with the expression vector of  claim 5 .  
     
     
         7 . The host cell of  claim 6 , wherein said cell is a microorganism.  
     
     
         8 . The host cell of  claim 7 , wherein said cell belongs to the genus  Corynebacterium  or  Brevibacterium.    
     
     
         9 . A method of producing a polypeptide comprising culturing the host cell of  claim 6  in an appropriate culture medium to, thereby, produce the polypeptide.  
     
     
         10 . A method for producing a fine chemical, comprising culturing the cell of  claim 6  such that the fine chemical is produced.  
     
     
         11 . The method of  claim 10 , wherein said method further comprises the step of recovering the fine chemical from said culture.  
     
     
         12 . The method of  claim 10 , wherein said cell belongs to the genus  Corynebacterium  or  Brevibacterium.    
     
     
         13 . The method of  claim 10 , wherein said cell is selected from the group consisting of  Corynebacterium glutamicum, Corynebacterium herculis, Corynebacterium, lilium, Corynebacterium acetoacidophilum, Corynebacterium acetoglutamicum, Corynebacterium acetophilum, Corynebacterium ammoniagenes, Corynebacterium fujiokense, Corynebacterium nitrilophilus, Brevibacterium ammoniagenes, Brevibacterium butanicum, Brevibacterium divaricatum, Brevibacterium flavum, Brevibacterium healii, Brevibacterium ketoglutamicum, Brevibacterium ketosoreductum, Brevibacterium lactofermentum, Brevibacterium linens, Brevibacterium paraffinolyticum , and those strains set forth in Table 3.  
     
     
         14 . The method of  claim 10 , wherein expression of the nucleic acid molecule from said vector results in modulation of production of said fine chemical.  
     
     
         15 . The method of  claim 10 , wherein said fine chemical is selected from the group consisting of organic acids, proteinogenic and nonproteinogenic amino acids, purine and pyrimidine bases, nucleosides, nucleotides, lipids, saturated and unsaturated fatty acids, diols, carbohydrates, aromatic compounds, vitamins, cofactors, polyketides, and enzymes.  
     
     
         16 . The method of  claim 10 , wherein said fine chemical is an amino acid selected from the group consisting of lysine, glutamate, glutamine, alanine, aspartate, glycine, serine, threonine, methionine, cysteine, valine, leucine, isoleucine, arginine, proline, histidine, tyrosine, phenylalanine, and tryptophan.  
     
     
         17 . An isolated polypeptide selected from the group consisting of 
 a) an isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 86, 88 or 90;    b) an isolated polypeptide comprising a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence of SEQ ID NO: 86, 88 or 90;    c) an isolated polypeptide which is encoded by a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:85, 87 or 89;    d) an isolated polypeptide which is encoded by a nucleic acid molecule comprising a nucleotide sequence which is at least 50% identical to the entire nucleotide sequence of SEQ ID NO:85, 87 or 89;    e) an isolated polypeptide comprising an amino acid sequence which is at least 50% identical to the entire amino acid sequence of SEQ ID NO: 86, 88 or 90; and    f) an isolated polypeptide comprising a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO: 86, 88 or 90, wherein said polypeptide fragment maintains a biological activity of the polypeptide comprising the amino sequence.    
     
     
         18 . The isolated polypeptide of  claim 17 , wherein said polypeptide is involved in the production of a fine chemical.  
     
     
         19 . The isolated polypeptide of  claim 17 , further comprising heterologous amino acid sequences.  
     
     
         20 . A method for diagnosing the presence or activity of  Corynebacterium diphtheriae  in a subject, comprising detecting the presence of at least one of the nucleic acid molecules of  claim 1 , thereby diagnosing the presence or activity of  Corynebacterium diphtheriae  in the subject.  
     
     
         21 . A method for diagnosing the presence or activity of  Corynebacterium diphtheriae  in a subject, comprising detecting the presence of at least one of the polypeptide molecules of  claim 17 , thereby diagnosing the presence or activity of  Corynebacterium diphtheriae  in the subject.  
     
     
         22 . A host cell comprising a nucleic acid molecule selected from the group consisting of 
 a) the nucleic acid molecule of SEQ ID NO:85, 87 or 89, wherein the nucleic acid molecule is disrupted by at least one technique selected from the group consisting of a point mutation, a truncation, an inversion, a deletion, an addition, a substitution and homologous recombination;    b) the nucleic acid molecule of SEQ ID NO:85, 87 or 89, wherein the nucleic acid molecule comprises one or more nucleic acid modifications as compared to the sequence of SEQ ID NO:85, 87 or 89, wherein the modification is selected from the group consisting of a point mutation, a truncation, an inversion, a deletion, an addition and a substitution; and    c) the nucleic acid molecule of SEQ ID NO:85, 87 or 89, wherein the regulatory region of the nucleic acid molecule is modified relative to the wild-type regulatory region of the molecule by at least one technique selected from the group consisting of a point mutation, a truncation, an inversion, a deletion, an addition, a substitution and homologous recombination.

Join the waitlist — get patent alerts

Track US2007231259A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.